Merkel cell carcinoma
Zynyz Approved for Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma
The FDA granted accelerated approval to retifanlimab-dlwr (Zynyz, Incyte) for adult patients with metastatic or ...
APRIL 5, 2023
MCC Rx Marks First Use of Real-World Data for FDA Approval
Retrospective analysis used iKnowMed EHR data from McKesson U.S. Pharmaceutical and Specialty Health.
SEPTEMBER 13, 2018
Long-Term Benefit Seen With Avelumab in Merkel Cell Ca
Washington—Avelumab was associated with a rate of survival in patients with metastatic Merkel cell carcinoma ...
JUNE 20, 2017
FDA Approves First Treatment for MCC
The drug was approved for the treatment of adults and pediatric patients 12 years and older with metastatic MCC, ...
MARCH 23, 2017
Avelumab Granted Priority Review to Treat Metastatic Merkel Cell Carcinoma
A review has been submitted for the proposed use of the investigational immunotherapy in patients with metastatic ...
NOVEMBER 29, 2016